Rifaximin

£115,000.00

Rifaximin is a specialized, gut-selective antibiotic essential for treating a range of gastrointestinal disorders, including traveler’s diarrhea, irritable bowel syndrome with diarrhea (IBS-D), and hepatic encephalopathy. Its minimal systemic absorption provides a superior safety profile, making it a critical choice for healthcare providers seeking effective, localized treatment. This distinct mechanism of action positions Rifaximin as a leader in advanced GI health solutions, offering significant value in a rapidly expanding pharmaceutical market. Partner with us for a reliable supply of this high-demand active pharmaceutical ingredient.

Description

Product Overview

Rifaximin is a high-purity, semi-synthetic antibiotic derived from rifamycin, formulated for industrial and pharmaceutical-grade applications. It is primarily utilized for the production of oral formulations targeting gastrointestinal infections, including traveler’s diarrhea, hepatic encephalopathy prevention, and bacterial overgrowth disorders. Strategically, Rifaximin provides a superior efficacy profile with minimal systemic absorption, making it a preferred choice in global pharmaceutical manufacturing. Its stability, reproducible quality, and regulatory compliance ensure it is a critical asset for manufacturers aiming to maintain competitive advantage in the enteric antibiotic market. With strong industrial relevance, Rifaximin supports high-demand production lines and consistent product performance.


Key Specifications & Technical Characteristics

  • Chemical Composition: C43H51N3O11
  • Purity Level / Grade: ≥ 98% (Pharmaceutical/Industrial Grade)
  • Physical Form: Fine crystalline powder
  • Color: Off-white to pale yellow
  • Particle Size: Micronized for uniform blending
  • Density: Approx. 1.3 g/cm³
  • Solubility: Practically insoluble in water; soluble in dimethyl sulfoxide (DMSO)
  • Packaging Options: 25 kg kraft paper drums with inner polyethylene lining; custom packaging available upon request
  • Shelf Life: 36 months under recommended storage conditions (cool, dry, and dark environment)

Core Industrial Applications

  • Pharmaceutical Industry:
    • Production of oral tablets, capsules, and powders for treating gastrointestinal infections.
    • Used in formulations targeting traveler’s diarrhea, hepatic encephalopathy prevention, and irritable bowel conditions.
  • Operational Advantages:
    • Minimal systemic absorption ensures high local efficacy in the gut.
    • Superior stability allows long shelf life and consistent dosage performance.
    • Compatible with various excipients and scalable manufacturing processes.
  • Efficiency & Cost Advantages:
    • Reduces formulation variability and batch failure risk.
    • High purity grade minimizes processing losses and downstream purification costs.

Competitive Advantages

  • Quality Consistency: Stringent GMP-compliant production ensures uniform pharmaceutical-grade quality.
  • Supply Reliability: Secure, scalable supply chain capable of meeting global industrial demand.
  • Logistics Capability: Optimized for bulk shipment with compliant handling for pharmaceutical intermediates.
  • Price Competitiveness: Competitive bulk pricing for high-volume industrial buyers.
  • Sustainability & Compliance: Manufactured under environmentally responsible processes; supports green chemistry initiatives.
  • Technical Support: Comprehensive documentation, including Certificates of Analysis (CoA) and regulatory compliance support.

Commercial & Supply Information

  • Minimum Order Quantity (MOQ): BULK 20 MT
  • Loading Capacity: 20 MT per 20-foot container (standard bulk shipping)

Rifaximin represents a strategic, high-value sourcing choice for industrial and pharmaceutical manufacturers seeking quality, reliability, and performance in enteric antibiotic production.

Reviews

There are no reviews yet.

Be the first to review “Rifaximin”

Your email address will not be published. Required fields are marked *

Add to cart